1. Cancer Vaccines
   Jay A. Berzofsky et al, 2023, Plotkin's Vaccines CrossRef
2. A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response
   Jamie Wallis et al, 2020, European Journal of Pharmaceutical Sciences CrossRef
3. From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy
   Jing-Jing Du et al, 2023, Frontiers in Chemistry CrossRef
4. Breast Cancer and Immunosenescence
   Mauro Provinciali et al, 2019, Handbook of Immunosenescence CrossRef
5. Antigen-specific active immunotherapy for ovarian cancer
   Sterre T Paijens et al, 2018, Cochrane Database of Systematic Reviews CrossRef
6. Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells
   Marco Dionisi et al, 2018, Frontiers in Immunology CrossRef
7. Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models
   Alfredo Perales-Puchalt et al, 2019, Molecular Therapy CrossRef
8. Tumorvakzinierung –Strategien und Timing
   Yacine Maringer et al, 2021, Der Gastroenterologe CrossRef
9. Breast cancer, placenta and pregnancy
   Karolin Froehlich et al, 2019, European Journal of Cancer CrossRef
10. Tumorvakzinierung –Strategien und Timing
    Yacine Maringer et al, 2021, Der Internist CrossRef
11. Role of Immunotherapy in the Treatment of Cancer: A Systematic Review
    Sia Pei Ling et al, 2022, Cancers CrossRef
12. A Tumor-Peptide–Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Antitumor Immunotherapy
    Carolin Heße et al, 2019, Molecular Cancer Therapeutics CrossRef
13. Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects
    Azam Bozorgi et al, 2022, Cellular Oncology CrossRef
14. Peptide Vaccines as Therapeutic and Prophylactic Agents for Female-Specific Cancers: The Current Landscape
    Manju Lekshmy et al, 2023, Pharmaceuticals CrossRef
15. Peptide‐based therapeutic cancer vaccine: Current trends in clinical application
    Wensi Liu et al, 2021, Cell Proliferation CrossRef
16. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
    Jiangping Li et al, 2023, Molecular Cancer CrossRef
17. Breast Cancer and Immunosenescence
    Mauro Provinciali et al, 2018, Handbook of Immunosenescence CrossRef
18. Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis
    U. Dafni et al, 2021, European Journal of Cancer CrossRef
19. Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations
    Aussara Panya et al, 2023, Biomedicine & Pharmacotherapy CrossRef
20. Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL)
    Chiara Napoletano et al, 2020, Cancers CrossRef
21. Next Generation Cancer Vaccines—Make It Personal!
    Angelika Terbuch et al, 2018, Vaccines CrossRef
22. Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review
    María Lilia Nicolás-Morales et al, 2022, Vaccines CrossRef
23. Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells
    Federico Battisti et al, 2017, Frontiers in Immunology CrossRef
24. Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses
    Katrin Campbell et al, 2021, Vaccines CrossRef
25. A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer
    Patrick M. Dillon et al, 2017, Journal for ImmunoTherapy of Cancer CrossRef